GrowingStockReport.com

NASDAQ Gainers Watch List: Paychex, Inc. (NASDAQ:PAYX) and Celldex Therapeutics, Inc. (NASDAQ:CLDX) Added to Growing Stock Report's NASDAQ Gainers Watch List.

 

New York, NY -- (ReleaseWire) -- 02/13/2014 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Paychex, Inc. (NASDAQ:PAYX) and Celldex Therapeutics, Inc. (NASDAQ:CLDX).

Paychex, Inc. (NASDAQ:PAYX) a company that is a provider of payroll, human resource, and benefits outsourcing solutions for small to medium-sized businesses closed up in its previous session (+0.73%) on 2,126,884 shares traded. Paychex, Inc. (NASDAQ:PAYX) is currently up (+27.34%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Paychex, Inc. (NASDAQ:PAYX)

Celldex Therapeutics, Inc. (NASDAQ:CLDX) a biopharmaceutical company that focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States closed up in its previous session (+7.20%) on 3,006,674 shares traded. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is currently up (+264.34%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Celldex Therapeutics, Inc. (NASDAQ:CLDX)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com